MHICC is a clinical research organisation and trusted partner in the execution of investigator-initiated trials and pharmaceutical/biotech clinical programmes with decentralised trial solutions.
Astral Systems is addressing the impending shortage of life-saving medical isotopes in the nuclear medicine industry through its groundbreaking isotope production technology.